One study is available examining the efficacy of desipramine in the treatment of adult ADHD. The six-week, double-blind, placebo-controlled study assessed the differences in the reduction of ADHD symptoms in adults receiving desipramine or placebo. The research suggests that 68% of subjects receiving desipramine responded to treatment, compared with none of the subjects who received [...]

Atomoxetine (Strattera drug, Eli Lilly), a selective norepinephrine reuptake inhibitor (SNRI), is indicated for the treatment of ADHD in children and specifically in adults. As one of the only drugs with FDA approval for adult ADHD, atomoxetine has the most evidence available in the literature to support such use.

Stimulants A wealth of evidence supports the use of stimulants in the treatment of ADHD in children. According to the evidence-based clinical practice guideline for outpatient evaluation and management of ADHD produced by the Cincinnati Children’s Hospital Medical Center, stimulants are first-line therapy in treatment plans requiring medications in children with ADHD. Stimulants approved for [...]

Introduction For many years, attention-deficit/hyperactivity disorder (ADHD) was considered a neuropsychological condition occurring strictly during childhood and adolescence. However, approximately 30% to 70% of children with ADHD continue to have symptoms into adulthood. The estimated U.S. prevalence of adult ADHD is 1% to 7%. In the last few years, the manifestation of the condition in [...]